CRDC, GNET, LCI, KTEC, ACY, NBY Expected To Be Down After Next Earnings Releases
November 10, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, November 11th 2010 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and November earnings reports. CARDICA INC (NASDAQ:CRDC), GLOBAL TRAFFIC NETWORK INC (NASDAQ:GNET), LANNETT CO INC (AMEX:LCI), KEY TECHNOLOGY INC (NASDAQ:KTEC), AEROCENTURY CORP (AMEX:ACY), NOVABAY PHARMACEUTICALS INC (AMEX:NBY) are all expected to be Down After their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:
Symbol Company # of Reports Quarter Release Time CRDC CARDICA INC 12 Quarter Q1 After GNET GLOBAL TRAFFIC NETWORK INC 12 Quarter Q1 Before LCI LANNETT CO INC 12 Quarter Q1 After KTEC KEY TECHNOLOGY INC 12 Quarter Q4 After ACY AEROCENTURY CORP November Earnings Q3 Before NBY NOVABAY PHARMACEUTICALS INC 12 Quarter Q3 During
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
CARDICA INC (NASDAQ:CRDC) - Cardica, Inc. designs and manufactures medical devices for cardiac and other surgical procedures based on its proprietary stapling and cutting technology. It designs and manufactures its automated anastomosis product line, the C-Port Distal Anastomosis systems and PAS-Port Proximal Anastomosis system to automate the joining of blood vessels for the coronary artery bypass graft (CABG) surgery market. The company develops the C-Port Flex A Anastomosis system to enable automated anastomoses, or the joining of blood vessels, to be performed as part of minimally invasive and surgical robot-facilitated CABG procedures. In addition, Cardica is developing the Microcutter, a true multi-fire endoscopic stapling device designed to be used in a various procedures, including bariatric, thoracic, and general surgery. The company was founded in 1997 and is based in Redwood City, California.
GLOBAL TRAFFIC NETWORK INC (NASDAQ:GNET) - Global Traffic Network, Inc., through its subsidiaries, provides traffic and news information reports to radio and television stations. It offers traffic information reports to radio stations in Australia, Canada, and the United Kingdom; television traffic reports in Australia and Canada; radio entertainment news reports in the United Kingdom; and news information reports to radio stations in Canada. The company offers its services in exchange for commercial airtime inventory that it in turn sells to advertisers. Global Traffic Network, Inc. was founded in 1997 and is based in New York, New York.
LANNETT CO INC (AMEX:LCI) - Lannett Company, Inc. develops, manufactures, markets, and distributes generic versions of pharmaceutical products in the United States. The company manufactures and/or sells various prescription products. Its product portfolio includes acetazolamide, baclofen, and bethanechol chloride tablets; amantadine gel capsules; butalbital, aspirin, and caffeine with codeine phosphate, danazol, and clindamycin HCl capsules; cocaine topical solution; and dicyclomine tablets and capsules. The companys products also comprise digoxin, dipyridamole, doxycycline, doxycycline hyclate, esterified estrogen and methyltestoterone, hydrochlorothiazide, hydromorphone HCl, and levothyroxine sodium tablets; morphine sulfate oral solutions; and OB-natal one gel capsules. In addition, its products consist of pilocarpine HCl, primidone, probenecid, terbutaline sulfate, and unithroid tablets; oxycodone HCl oral solution; rifampin and ursodiol capsules; and phentermine HCl tablets and capsules. Lannett Company markets its products under the brand names of Diamox, Symmetrel, Lioresal, Urecholine, Fiorinal, Cleocin, Danocrine, Bentyl, Lanoxin, Persantine, Adoxa, Periostat, Estratest, Hydrodiuril, Dilaudid, Levoxyl/ Synthroid, Roxanol, PrimaCare ONE, Roxicodone, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Actigall, and Fiorinal w/ Codeine #3. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
KEY TECHNOLOGY INC (NASDAQ:KTEC) - Key Technology, Inc. and its subsidiaries design, manufacture, and sell process automation systems, integrating electro-optical inspection and sorting, specialized conveying and product preparation equipment to the food processing, tobacco, and pharmaceutical industries. Its automated inspection systems are used in various applications to detect and remove defects and foreign material from the product stream. The company offers Manta, an optical sorter; Tegra, which inspects product in-air using cameras configured in a tilted-X geometry that look at oblique angles; the Optyx family of sorters that offers a combination of on-belt and in-air sorting; Tobacco Sorter 3 tobacco sorting systems used in tobacco threshing and primary processing; ADR automatic defect removal systems used in the potato strip industry; and Optyx SG and VeriSym used in the pharmaceutical and nutraceutical industry. It also provides conveying and process systems, including the SmartShaker vibratory solutions, including Iso-Flo and Impulse branded systems combining material handling with various processing functions in addition to vibratory conveying; Farmco rotary grading systems; Turbo-Flo steam blanchers; Freshline equipment for fresh-cut produce; and SYMETIX equipment for pharmaceuticals and nutraceuticals. In addition, the company offers process systems, including standard and custom designed equipment that conveys, transfers, distributes, aligns, feeds, meters, separates, grades, blanches, cooks, pasteurizes, cools, cleans, washes, dries, polishes, and packages products. Further, Key Technology provides spare parts, and post-sale field and telephone-based repair services. It markets its products directly and through independent sales representatives in the United States and internationally. The company was founded in 1948 and is headquartered in Walla Walla, Washington.
AEROCENTURY CORP (AMEX:ACY) - AeroCentury Corp. invests in used regional aircraft and aircraft engines for lease to foreign and domestic regional carriers. The company owns regional aircraft and engines, and leases it to customers under triple net operating leases in Europe, the Caribbean, central America, Asia, the United States, Africa, and South America. As of December 31, 2009, AeroCentury Corp. owned 8 deHavilland DHC-8-300s, 3 deHavilland DHC-8-100s, 3 deHavilland DHC-6s, 14 Fokker 50s, 2 Saab 340As, 6 Saab 340Bs, 7 Fokker 100s, and 3 General Electric CF34-8E aircraft engines, which were on lease or held for lease. The company was founded in 1989 and is headquartered in Burlingame, California.
NOVABAY PHARMACEUTICALS INC (AMEX:NBY) - NovaBay Pharmaceuticals Inc., a clinical stage specialty pharmaceutical company, engages in the discovery and development of product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments. Its Aganocide compounds are synthetic forms of N-chlorinated antimicrobial molecules, which are anti-infective molecules produced by white blood cells when defending the body against invading pathogens. These compounds could form a platform to create various products to address the needs in the treatment and prevention of bacterial, viral, and fungal infections. The companys lead product candidate, NVC-422, is used for the treatment of eye, ear, and sinus infections, and for use in contact lens solutions, as well as to destroy bacteria in the bladder, and bacteria that have formed biofilm within the catheter. It also develops NVC-101, a solution of hypochlorous acid used as a wound cleanser and debriding agent. NovaBay Pharmaceuticals has a licensing and research collaboration agreement with Alcon Manufacturing Ltd. for use of its Aganocide compounds in the eye, ear, and sinus infections, and for contact lens care, as well as an agreement with Galderma S.A. to develop and commercialize its Aganocide compounds in acne, impetigo, and other dermatological indications. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals was incorporated in 2000 and is based in Emeryville, California.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641